OCX Message Board Post 9880724 | Oncocyte Corporation
home / stock / ocx / ocx message board
cclaude
(investorshub)
Posted on: Jun/29/2020 21:04:59
Source: investorshub
https://investorshub.advfn.com/boards/read_msg.aspx?message_id=156601484
total garbage ...DETERMADX...didn`t meet endpoint....company ending research....
News, Short Squeeze, Breakout and More Instantly...
-
(NewsDirect) Chronic conditions such as organ transplant rejection and cancer represent significant challenges in modern healthcare, demanding precise diagnostic tools for effective management and treatment. For organ transplant patients, the risk of graft rejection remains a persistent threa...
-
NEW YORK, June 03, 2024 (GLOBE NEWSWIRE) -- Oncocyte’s (Nasdaq: OCX) VitaGraft Kidney™ diagnostic test for transplant monitoring has shown promising results in a Phase 2 clinical trial, published in the prestigious New England Journal of Medicine. The trial evaluated the test's effe...
-
Late-breaking presentation of data at American Transplant Congress on Monday, June 3 Data show potential to monitor for therapeutic efficacy and recurrence Potential repeat testing opportunities with claims expansion IRVINE, Calif., May 30, 2024 (GLOBE NEWSWIRE) -- Oncocyte Corp...